Lipid-based nanoparticles external triggered release strategies in cancer nanomedicine
{{output}}
Nearly half of humanity will develop cancer in their Lifetime. Current therapies, particularly chemotherapeutic drugs, face significant challenges due to the lack of tissue-specific delivery. For example, less than 0.1% of anticancer drugs administered systemi... ...